HAMBURG (dpa-AFX) - Evotec AG (EVTCY.PK, EVOTF.PK), a German drug discovery alliance and development partnership company, said that its shareholders approved all proposals the Company's Management put to vote at the Company's Annual General Meeting, which took place today, with the required majority.
At the Annual General Meeting 2016, the actions of the members of the Management Board and the Supervisory Board for the fiscal year 2015 were approved. The Annual General Meeting also approved a new resolution authorising the issuance of convertible bonds and/or warrant-linked bonds, participation rights and/or income bonds and the creation of new contingent capital.
Moreover, the Annual General Meeting passed the other agenda items requiring shareholders' approval, hereunder amendments to the Articles of Association and the appointment of Ernst & Young GmbH Wirtschaftspr?fungsgesellschaft, Hamburg, as the auditor for fiscal year 2016.
Copyright RTT News/dpa-AFX